Drug Delivery: Enabling Technology for Drug Discovery and Development. iPRECIO® Micro Infusion Pump: Programmable, Refillable, and Implantable
暂无分享,去创建一个
[1] M. Zaretskaia,et al. Stress-free microinjections in conscious rats , 2011, Journal of Neuroscience Methods.
[2] Martin Wehling,et al. Assessing the translatability of drug projects: what needs to be scored to predict success? , 2009, Nature Reviews Drug Discovery.
[3] S. Gad,et al. Nonclinical Vehicle Use in Studies by Multiple Routes in Multiple Species , 2006, International journal of toxicology.
[4] Chikara Abe,et al. A novel type of implantable and programmable infusion pump for small laboratory animals. , 2009, Journal of pharmacological and toxicological methods.
[5] T. Abribat,et al. The rise and rise of drug delivery , 2005, Nature Reviews Drug Discovery.
[6] Walter A. Korfmacher,et al. Advances in the integration of drug metabolism into the lead optimization paradigm. , 2009, Mini reviews in medicinal chemistry.
[7] John Higgins,et al. Strategies for bringing drug delivery tools into discovery. , 2011, International journal of pharmaceutics.
[8] Seshadri Neervannan,et al. Preclinical formulations for discovery and toxicology: physicochemical challenges , 2006, Expert opinion on drug metabolism & toxicology.
[9] R. Strickley. Solubilizing Excipients in Oral and Injectable Formulations , 2004, Pharmaceutical Research.
[10] Johan Gabrielsson,et al. Optimising in vivo pharmacology studies--Practical PKPD considerations. , 2010, Journal of pharmacological and toxicological methods.
[11] Katsuya Harada,et al. Chronic treatment with olanzapine via a novel infusion pump induces adiposity in male rats. , 2011, Life sciences.
[12] Chikara Abe,et al. Vestibular-mediated increase in central serotonin plays an important role in hypergravity-induced hypophagia in rats. , 2010, Journal of applied physiology.
[13] Johan Gabrielsson,et al. Pharmacokinetic-pharmacodynamic reasoning in drug discovery and early development. , 2009, Future medicinal chemistry.
[14] V. Pillay,et al. Drug delivery technologies for chronotherapeutic applications , 2009, Pharmaceutical development and technology.
[15] T. Kenakin. Statistics and Experimental Design , 2019, A Pharmacology Primer.
[16] D. K. Walker,et al. The use of pharmacokinetic and pharmacodynamic data in the assessment of drug safety in early drug development. , 2004, British journal of clinical pharmacology.
[17] Richard A. Greenberg,et al. Statistics and Experimental Design , 1970, The Yale Journal of Biology and Medicine.
[18] Ping Li,et al. Developing early formulations: practice and perspective. , 2007, International journal of pharmaceutics.
[19] R. Strickley. Formulation in Drug Discovery , 2008 .
[20] Jochen Maas,et al. An integrated early formulation strategy--from hit evaluation to preclinical candidate profiling. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[21] I. Inglis,et al. Refining procedures for the administration of substances , 2001, Laboratory animals.
[22] E. Kwong,et al. Strategies at the interface of drug discovery and development: early optimization of the solid state phase and preclinical toxicology formulation for potential drug candidates. , 2010, Journal of medicinal chemistry.
[23] M. Wehling,et al. The translatability of animal models for clinical development: biomarkers and disease models. , 2010, Current opinion in pharmacology.
[24] Brian Samas,et al. An intravenous formulation decision tree for discovery compound formulation development. , 2003, International journal of pharmaceutics.
[25] D. Gustafson,et al. Optimizing preclinical study design in oncology research. , 2011, Chemico-biological interactions.